Ontology highlight
ABSTRACT: This a model from the article: This model was taken from the CellML repository and automatically converted to SBML. This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2011 The BioModels.net Team. In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not..
A dynamical perspective of CTL cross-priming and regulation: implications forcancer immunology.
Wodarz D, Jansen VA. Immunol Lett 2003 May 1;86(3):213-27 12706524 ,
Abstract:
Cytotoxic T lymphocytes (CTL) responses are required to fight many diseases suchas viral infections and tumors. At the same time, they can cause disease wheninduced inappropriately. Which factors regulate CTL and decide whether theyshould remain silent or react is open to debate. The phenomenon calledcross-priming has received attention in this respect. That is, CTL expansionoccurs if antigen is recognized on the surface of professional antigenpresenting cells (APCs). This is in contrast to direct presentation whereantigen is seen on the surface of the target cells (e.g. infected cells or tumorcells). Here we introduce a mathematical model, which takes the phenomenon ofcross-priming into account. We propose a new mechanism of regulation which isimplicit in the dynamics of the CTL: According to the model, the ability of aCTL response to become established depends on the ratio of cross-presentation todirect presentation of the antigen. If this ratio is relatively high, CTLresponses are likely to become established. If this ratio is relatively low,tolerance is the likely outcome. The behavior of the model includes a parameterregion where the outcome depends on the initial conditions. We discuss ourresults with respect to the idea of self/non-self discrimination and the dangersignal hypothesis. We apply the model to study the role of CTL in cancerinitiation, cancer evolution/progression, and therapeutic vaccination againstcancers.
The original model was: Wodarz D, Jansen VA. (2003) - version=1.0
The original CellML model was created by:
Catherine Lloyd
c.lloyd@auckland.ac.nz
The University of Auckland
To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.
ORGANISM(S): Homo sapiens
SUBMITTER: Lucian Smith
PROVIDER: MODEL1006230094 | biostudies-other |
SECONDARY ACCESSION(S): 12706524
REPOSITORIES: biostudies-other

Immunology letters 20030501 3
Cytotoxic T lymphocytes (CTL) responses are required to fight many diseases such as viral infections and tumors. At the same time, they can cause disease when induced inappropriately. Which factors regulate CTL and decide whether they should remain silent or react is open to debate. The phenomenon called cross-priming has received attention in this respect. That is, CTL expansion occurs if antigen is recognized on the surface of professional antigen presenting cells (APCs). This is in contrast t ...[more]